Amanote Research
Register
Sign In
Inflammatory Bowel Disease in the Clinic: Escalation and De-Escalation of Therapy: A Longitudinal Case-Based Discussion
Journal of Gastroenterology and Hepatology
- United Kingdom
doi 10.1111/jgh.13348
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Gastroenterology
Date
June 1, 2016
Authors
Jakob Begun
Publisher
Wiley
Related search
Prm2 - Identification of Dose-Escalation in Biologic Therapy Based on Claims Data: The Example of Patients With Inflammatory Bowel Disease
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Letter: Anti-TNF Dose De-Escalation in Crohn's Disease-A Case-By-Case Decision
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
AB1109 Dose De-Escalation in a Specialized Outpatient Clinic on Biological Therapy: Cost Minimization Observational Study
Editorial: Infliximab De-Escalation in Inflammatory Bowel Disease Using a Therapeutic Drug Monitoring Strategy - Early Promise but More Data Needed. Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Escalation and De-Escalation of Commitment in Response to Sunk Costs: The Role of Budgeting in Mental Accounting
Organizational Behavior and Human Decision Processes
Human Resource Management
Applied Psychology
Organizational Behavior
Prostaglandins in Inflammatory Bowel Disease Therapy
Canadian Journal of Gastroenterology
Inflammatory Bowel Disease - Case Report
Deutsche Medizinische Wochenschrift
Medicine
Escalation Strategies for Combination Therapy Phase I Trials
Pharmaceutical Statistics
Statistics
Probability
Pharmacology
Inflammatory Bowel Diseases in Children: Peculiarities of the Disease Course and Therapy
Medical Council
